Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
Coccidioidomycosis skin testing appears to be uncommon, based on US health insurance claims data. Patient demographic features were consistent with the approval of the test for adults, but few patients had previous coccidioidomycosis diagnosis codes supporting its use for detecting delayed-type hype...
Main Authors: | Kaitlin Benedict, Orion Z. McCotter, Brendan R. Jackson |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2020-03-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/26/3/19-0798_article |
Similar Items
-
Coccidioidomycosis and the skin: a comprehensive review
by: Sandra Cecilia Garcia Garcia, et al.
Published: (2015-10-01) -
Suspected Locally Acquired Coccidioidomycosis in Human, Spokane, Washington, USA
by: Hanna N. Oltean, et al.
Published: (2020-03-01) -
Enhanced Surveillance for Coccidioidomycosis, 14 US States, 2016
by: Kaitlin Benedict, et al.
Published: (2018-08-01) -
Pandora’s Box: Disseminated Coccidioidomycosis Associated with Self-Medication with an Unregulated Potent Corticosteroid Acquired in Mexico
by: Alejandro Jose Coba, et al.
Published: (2021-12-01) -
Coccidioidomycosis in a reference center in Northeast Brazil: clinical/epidemiological profile and most common radiological findings
by: José Leonardo da Silveira Morais, et al.
Published: (2020-10-01)